HIDROVIAS (HBSA3) Main Indicators
Basic Data - HBSA3
| Company | HIDROVIAS |
| Corporate Name | HIDROVIAS DO BRASIL S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Operador de logística hidroviária para clientes de commodities agrícolas. minerais. combustíveis e derivados e carga. integrando o transporte por barcaças com operação de terminais de origem e destino |
| Share | HBSA3 |
| Quote Date | 11/08/2024 |
| Share Type | ON |
| Last Closing | R$ 3.25 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 13.04 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Bens Industriais |
| Subsector | Transporte |
| Segment | Transporte Hidroviário |
| Participation Indexes | AGFS, GPTW, IBRA, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 11/09/2024 | |
Relative Prices - HBSA3
| Price/Earnings | -6.73 |
| Price/SBV | 1.88 |
| Price/Net Sales | 1.49 |
| Price/CFO | 7.99 |
| Price/FCF | 36.02 |
| Price/Total Assets | 0.38 |
| Price/EBIT | -96.67 |
| Price/Working Capital | -7.31 |
| Price/NCAV | -0.45 |
| EV/EBIT | -250.42 |
| EV/EBITDA | 17.55 |
| EV/Net Sales | 3.87 |
| EV/CFO | 20.69 |
| EV/FCF | 93.31 |
| EV/Total Assets | 0.98 |
| Company Market Cap | R$ 2.47 B |
| Enterprise Value | R$ 6.40 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 3.25 |
| Share Price Date | 11/08/2024 |
| Dividend Yield | 0.00% |
| Updated 11/09/2024 | |
Income Statement - HBSA3
| Net Revenue | R$ 1.65 B |
| Gross Result | R$ 314.53 M |
| EBIT | - R$ 25.56 M |
| Depreciation and Amortization | - R$ 390.35 M |
| EBITDA | R$ 364.79 M |
| Net Profit | - R$ 367.29 M |
| Net Profit/Share | - R$ 0.48 |
| Updated 11/08/2024 | |
| Net Revenue | R$ 489.39 M |
| Gross Result | R$ 138.90 M |
| EBIT | R$ 57.36 M |
| Depreciation and Amortization | - R$ 112.63 M |
| EBITDA | R$ 169.99 M |
| Net Profit | - R$ 48.64 M |
| Profit/Share | - R$ 0.06 |
| Updated 11/08/2024 | |
Price and Volume Behavior - HBSA3
| Lowest Price 52 weeks | R$ 3.07 |
| Highest Price 52 weeks | R$ 4.54 |
| Variation 2024 | -11.44% |
| Variation 1 year | -13.56% |
| Variation 2 years(total) | 6.91% |
| Variation 2 years(yearly) | 3.39% |
| Variation 3 years(total) | 15.25% |
| Variation 3 years(yearly) | 4.84% |
| Variation 4 years(total) | -50.98% |
| Variation 4 years(yearly) | -16.30% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 9.22 M |
| Updated 11/09/2024 | |
Returns and Margins - HBSA3
| Return on Initial Tangible Capital | -0.34% |
| Return on Initial Invested Capital | -0.32% |
| Pre-Tax Return on Initial Tangible Capital | -0.51% |
| Pre-Tax Return on Initial Invested Capital | -0.48% |
| Return on Initial Shareholder´s Equity | -23.17% |
| Return on Initial Asset | -5.73% |
| Gross Margin | 19.02% |
| Net Margin | -22.21% |
| EBIT Margin | -1.55% |
| EBITDA Margin | 22.06% |
| Initial Asset Turnover | 0.26 |
| Financial Leverage | 4.94 |
| Liabilities/Net Worth | 3.94 |
| Net Debt/EBITDA | 10.78 |
| Updated 11/08/2024 | |
Balance Sheet - HBSA3
| Cash and Cash Equivalents | R$ 686.99 M |
| Total Assets | R$ 6.51 B |
| Short-Term Debt | R$ 1.18 B |
| Long-Term Debt | R$ 3.44 B |
| Gross Debt | R$ 4.62 B |
| Net Debt | R$ 3.93 B |
| Shareholder´s Equity | R$ 1.32 B |
| Share Book Value | R$ 1.73 |
| Common Shares | 760,383,000 |
| Preferred Shares | 0 |
| Total | 760,383,000 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 760,383,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 760,383,000 |
| Updated 11/08/2024 | |
Cash Flow - HBSA3
| Operating Cash Flow | R$ 309.46 M |
| Cash Flow from Investments | - R$ 159.00 M |
| Financing Cash Flow | - R$ 141.44 M |
| Increase (Reduction) in Cash and Equivalents | R$ 38.20 M |
| Updated 11/08/2024 | |
| Operating Cash Flow | R$ 43.62 M |
| Cash Flow from Investments | - R$ 84.39 M |
| Financing Cash Flow | - R$ 41.27 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 92.20 M |
| Updated 11/08/2024 | |
Experimental - HBSA3
| CAPEX 3 months | - R$ 70.50 M |
| Free Cash Flow 3 months | - R$ 26.88 M |
| CAPEX 12 months | - R$ 240.85 M |
| Free Cash Flow 12 months | R$ 68.61 M |
| Updated 11/08/2024 | |